Overview

Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine

Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
Migraine is a common disabling neurological condition that significantly affects quality of life. While traditional prophylactic treatments (e.g., beta-blockers, antiepileptics) are effective, they may be associated with side effects leading to poor adherence. Recent evidence suggests that nutraceuticals like magnesium, riboflavin, and coenzyme Q10 may provide a safer alternative. This study aims to compare the efficacy and tolerability of these two approaches.
Phase:
PHASE3
Details
Lead Sponsor:
Fayoum University
Treatments:
Magnesium
Propranolol